MiniMed Group Inc
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is MMED moving today?
Minimed Group Inc is a scaled medical technology company that develops, manufactures, and markets a comprehensive suite of solutions for the management of diabetes. It serves PWD who require intensive insulin therapy, which represents all people with T1D and a subset of those with T2D. The company's platform of simple and clinically effective solutions for PWD requiring insulin therapy includes Automated Insulin Delivery (AID) Systems and Smart Multiple Daily Injection (MDI) Systems. It derives revenue from the sale of products focused on diabetes management, including insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens. Geographically, it operates in the USA and the Rest of World, with the majority of revenue derived from the Rest of World.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
MMED overview
Related filings and maps
Congress activity in MMED
No receipt-qualified Congressional disclosure is present for MMED in the cached public ledger.
MMED contract awards, year to date.
Public federal awards linked to this ticker.
MMED lobbying filings, year to date.
Registered lobbying filings matched to MiniMed Group Inc.
MINIMED GROUP, INC.
MINIMED GROUP, INC.
MEHLMAN CONSULTING, INC.